Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig03201 |
---NA--- |
545 |
0 |
|
|
0 |
|
|
|
contig03202 |
diacylglycerol o-acyltransferase 2 |
468 |
20 |
4.86E-41 |
69.50% |
6 |
C:microsome; C:proton-transporting two-sector ATPase complex; F:diacylglycerol O-acyltransferase activity; P:triglyceride biosynthetic process; C:integral to membrane; F:2-acylglycerol O-acyltransferase activity |
EC:2.3.1.20; EC:2.3.1.22 |
|
contig03203 |
---NA--- |
469 |
0 |
|
|
0 |
|
|
|
contig03204 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig03205 |
---NA--- |
329 |
0 |
|
|
0 |
|
|
|
contig03206 |
cxorf33 precursor |
259 |
20 |
1.13E-29 |
74.55% |
2 |
F:F; C:C |
|
|
contig03207 |
---NA--- |
566 |
0 |
|
|
0 |
|
|
|
contig03208 |
---NA--- |
247 |
0 |
|
|
0 |
|
|
|
contig03209 |
hydroxysteroid (17-beta) dehydrogenase 7 |
248 |
20 |
2.24E-14 |
86.50% |
3 |
F:oxidoreductase activity; P:metabolic process; F:binding |
|
|
contig03210 |
---NA--- |
1017 |
0 |
|
|
0 |
|
|
|
contig03211 |
---NA--- |
341 |
0 |
|
|
0 |
|
|
|
contig03212 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig03213 |
---NA--- |
621 |
0 |
|
|
0 |
|
|
|
contig03214 |
delta-6 fatty acyl desaturase |
755 |
20 |
2.11E-28 |
86.05% |
8 |
C:endoplasmic reticulum membrane; P:fatty acid biosynthetic process; F:oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water; F:iron ion binding; F:heme binding; P:electron transport; P:transport; C:integral to membrane |
EC:1.14.19.0 |
|
contig03215 |
---NA--- |
328 |
0 |
|
|
0 |
|
|
|
contig03216 |
---NA--- |
194 |
0 |
|
|
0 |
|
|
|
contig03217 |
rwd domain containing 4a |
1288 |
20 |
3.79E-84 |
83.00% |
0 |
|
|
|
contig03218 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig03219 |
---NA--- |
657 |
0 |
|
|
0 |
|
|
|
contig03220 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig03221 |
myosin regulatory light chain smooth muscle isoform |
974 |
20 |
1.32E-93 |
97.45% |
3 |
C:myosin complex; F:calcium ion binding; F:motor activity |
|
|
contig03222 |
atpase aaa domain containing 2 |
1058 |
20 |
5.96E-58 |
63.40% |
2 |
F:ATP binding; F:nucleoside-triphosphatase activity |
EC:3.6.1.15 |
|
contig03223 |
exonuclease 3 -5 domain-like 1 |
284 |
18 |
1.39E-16 |
67.78% |
2 |
F:hydrolase activity; F:binding |
|
|
contig03224 |
tp53 regulating kinase |
260 |
20 |
4.94E-09 |
90.00% |
6 |
P:protein amino acid phosphorylation; F:p53 binding; F:ATP binding; F:protein tyrosine kinase activity; C:nucleus; F:protein serine/threonine kinase activity |
EC:2.7.10.0; EC:2.7.11.0 |
|
contig03225 |
chromosome 10 open reading frame 97 |
832 |
20 |
4.82E-120 |
75.65% |
2 |
P:apoptosis; C:nucleus |
|
|
contig03226 |
eukaryotic translation initiation factor subunit 10 |
341 |
20 |
1.35E-11 |
98.50% |
8 |
F:translation initiation factor activity; F:adenylate cyclase activity; C:eukaryotic translation initiation factor 3 complex; F:protein binding; P:regulation of translational initiation; P:cAMP biosynthetic process; F:structural molecule activity; C:nucleus |
EC:4.6.1.1 |
|
contig03227 |
steroid receptor rna activator 1 |
324 |
20 |
1.91E-37 |
78.45% |
7 |
P:apoptosis; P:positive regulation of transcription from RNA polymerase II promoter; F:ligand-dependent nuclear receptor transcription coactivator activity; C:transcription factor complex; C:cell leading edge; C:ribonucleoprotein complex; P:cell proliferation |
|
|
contig03228 |
transcription factor mitochondrial |
422 |
20 |
4.74E-28 |
62.95% |
5 |
F:transcription cofactor activity; C:mitochondrial matrix; P:rRNA modification; P:transcription from mitochondrial promoter; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity |
|
|
contig03229 |
---NA--- |
266 |
0 |
|
|
0 |
|
|
|
contig03230 |
---NA--- |
478 |
0 |
|
|
0 |
|
|
|
contig03231 |
transducin -like 1 x-linked receptor 1 |
574 |
20 |
1.36E-29 |
99.60% |
9 |
P:chromatin modification; P:regulation of transcription, DNA-dependent; C:heterotrimeric G-protein complex; P:visual perception; P:ubiquitin cycle; F:GTPase activity; P:signal transduction; P:sensory perception of sound; C:nucleus |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig03232 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
contig03233 |
adp-ribosylation factor-like 8a |
405 |
20 |
2.70E-15 |
88.85% |
12 |
P:chromosome segregation; F:GTP binding; C:late endosome; C:lysosome; F:beta-tubulin binding; C:midbody; C:membrane; F:alpha-tubulin binding; C:spindle midzone; P:small GTPase mediated signal transduction; F:GDP binding; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig03234 |
---NA--- |
429 |
0 |
|
|
0 |
|
|
|
contig03235 |
loc613274 protein |
560 |
20 |
8.38E-34 |
92.30% |
2 |
P:P; C:C |
|
|
contig03236 |
---NA--- |
349 |
0 |
|
|
0 |
|
|
|
contig03237 |
nadh dehydrogenase 1 alpha |
524 |
20 |
1.78E-29 |
77.65% |
6 |
P:mitochondrial electron transport, NADH to ubiquinone; C:membrane fraction; F:NADH dehydrogenase (ubiquinone) activity; P:electron transport; P:transport; C:mitochondrial respiratory chain complex I |
EC:1.6.5.3 |
|
contig03238 |
sept8a protein |
281 |
20 |
2.16E-17 |
85.40% |
4 |
C:septin complex; P:cell cycle; F:protein binding; F:GTP binding |
|
|
contig03239 |
btb domain containing 5 |
252 |
20 |
3.44E-18 |
92.25% |
1 |
F:protein binding |
|
|
contig03240 |
mediator complex subunit 24 |
257 |
20 |
2.99E-30 |
96.20% |
8 |
P:thymus development; P:retinal cone cell development; P:regulation of transcription, DNA-dependent; F:receptor activity; P:nervous system development; P:transcription antitermination; ; P:transcription from RNA polymerase II promoter |
|
|
contig03241 |
---NA--- |
500 |
0 |
|
|
0 |
|
|
|
contig03242 |
transmembrane protein 223 |
392 |
19 |
2.47E-13 |
71.63% |
4 |
F:F; C:integral to membrane; C:membrane; P:P |
|
|
contig03243 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
contig03244 |
tubulin-specific chaperone a |
388 |
20 |
2.72E-36 |
88.20% |
4 |
F:unfolded protein binding; C:cytoplasm; P:tubulin complex assembly; C:microtubule |
|
|
contig03245 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
contig03246 |
---NA--- |
299 |
0 |
|
|
0 |
|
|
|
contig03247 |
---NA--- |
420 |
0 |
|
|
0 |
|
|
|
contig03248 |
---NA--- |
784 |
0 |
|
|
0 |
|
|
|
contig03249 |
nucleoporin 50kda |
299 |
20 |
2.43E-08 |
88.75% |
1 |
C:membrane |
|
|
contig03250 |
zinc h2c2 domain containing |
640 |
20 |
1.36E-37 |
61.90% |
3 |
F:nucleic acid binding; P:DNA integration; F:DNA binding |
|
|
contig03251 |
---NA--- |
486 |
0 |
|
|
0 |
|
|
|
contig03252 |
topoisomerase ii beta |
1181 |
2 |
3.90E-16 |
60.50% |
9 |
F:DNA topoisomerase (ATP-hydrolyzing) activity; F:DNA topoisomerase activity; P:DNA topological change; C:chromosome; P:DNA metabolic process; C:nucleus; F:nucleotide binding; F:ATP binding; F:isomerase activity |
|
|
contig03253 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig03254 |
---NA--- |
299 |
0 |
|
|
0 |
|
|
|
contig03255 |
---NA--- |
287 |
0 |
|
|
0 |
|
|
|
contig03256 |
sumo1 activating enzyme subunit 1 |
1013 |
20 |
1.70E-131 |
80.95% |
8 |
F:ligase activity; F:ubiquitin activating enzyme activity; F:enzyme activator activity; F:ATP-dependent protein binding; P:protein ubiquitination; C:nucleus; F:protein C-terminus binding; F:protein heterodimerization activity |
|
|
contig03257 |
apex nuclease 1 |
683 |
20 |
6.00E-114 |
87.40% |
14 |
P:DNA repair; F:endonuclease activity; F:DNA-(apurinic or apyrimidinic site) lyase activity; P:heart looping; F:DNA binding; F:oxidoreductase activity; F:magnesium ion binding; P:heart contraction; P:regulation of DNA binding; C:perinuclear region of cytoplasm; ; F:transcription coactivator activity; P:negative regulation of apoptosis; C:nucleus |
EC:4.2.99.18 |
|
contig03258 |
nuclear protein localization 4 homolog ( cerevisiae) |
725 |
20 |
8.60E-101 |
87.80% |
9 |
C:nuclear membrane-endoplasmic reticulum network; P:Golgi organization; F:protein binding; P:cellular membrane fusion; P:ubiquitin cycle; P:ER-associated protein catabolic process; C:nucleus; F:zinc ion binding; C:endoplasmic reticulum |
|
|
contig03259 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig03260 |
cullin 5 |
274 |
20 |
8.76E-43 |
95.25% |
6 |
F:ubiquitin protein ligase binding; P:ubiquitin-dependent protein catabolic process; P:ubiquitin cycle; F:ubiquitin-protein ligase activity; F:vasopressin activated calcium mobilizing receptor activity; C:Cul5-RING ubiquitin ligase complex |
EC:6.3.2.19 |
|
contig03261 |
probable thiopurine s-methyltransferase |
564 |
20 |
4.38E-86 |
81.80% |
4 |
F:thiopurine S-methyltransferase activity; P:metabolic process; C:cytoplasm; C:cell junction |
EC:2.1.1.67 |
|
contig03262 |
---NA--- |
445 |
0 |
|
|
0 |
|
|
|
contig03263 |
---NA--- |
222 |
0 |
|
|
0 |
|
|
|
contig03264 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
contig03265 |
nsfl1 cofactor |
249 |
20 |
3.56E-12 |
83.50% |
6 |
C:Golgi apparatus; C:nucleus; F:protein binding; F:lipid binding; P:cellular membrane fusion; P:Golgi organization |
|
|
contig03266 |
ccr4-not transcription subunit 10 |
652 |
20 |
1.47E-87 |
85.25% |
1 |
F:binding |
|
|
contig03267 |
zinc cchc domain containing 4 |
1629 |
20 |
0 |
73.70% |
3 |
P:methylation; F:zinc ion binding; F:methyltransferase activity |
EC:2.1.1.0 |
|
contig03268 |
---NA--- |
104 |
0 |
|
|
0 |
|
|
|
contig03269 |
---NA--- |
446 |
0 |
|
|
0 |
|
|
|
contig03270 |
chloride nucleotide- 1a |
1078 |
20 |
4.85E-71 |
75.00% |
4 |
P:axon extension involved in development; P:chloride transport; P:cell volume homeostasis; C:intracellular part |
|
|
contig03271 |
---NA--- |
190 |
0 |
|
|
0 |
|
|
|
contig03272 |
tyrosyl-trna synthetase mitochondrial |
636 |
20 |
4.18E-31 |
84.40% |
5 |
P:tyrosyl-tRNA aminoacylation; F:tyrosine-tRNA ligase activity; F:protein binding; C:mitochondrial matrix; F:ATP binding |
EC:6.1.1.1 |
|
contig03273 |
---NA--- |
265 |
0 |
|
|
0 |
|
|
|
contig03274 |
dead (asp-glu-ala-asp) box polypeptide 1 |
335 |
20 |
2.31E-27 |
94.45% |
10 |
F:RNA binding; F:ATP-dependent helicase activity; P:spliceosome assembly; P:ribosome biogenesis; P:spermatogenesis; F:ATP binding; F:protein binding; P:regulation of translational initiation; P:multicellular organismal development; F:RNA helicase activity |
|
|
contig03275 |
---NA--- |
417 |
0 |
|
|
0 |
|
|
|
contig03276 |
---NA--- |
628 |
0 |
|
|
0 |
|
|
|
contig03277 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig03278 |
dehydrogenase reductase sdr family member 4 |
359 |
6 |
7.80E-19 |
91.33% |
1 |
F:oxidoreductase activity |
|
|
contig03279 |
fumarate hydratase |
472 |
20 |
1.33E-14 |
88.90% |
6 |
C:tricarboxylic acid cycle enzyme complex; P:homeostasis of number of cells within a tissue; P:fumarate metabolic process; P:tricarboxylic acid cycle; C:mitochondrion; F:fumarate hydratase activity |
EC:4.2.1.2 |
|
contig03280 |
drebrin-like |
251 |
20 |
1.30E-38 |
96.10% |
14 |
C:ruffle; P:actin filament bundle assembly; P:barbed-end actin filament capping; C:dendrite; F:protein C-terminus binding; F:actin filament binding; F:identical protein binding; P:actin filament severing; P:immune response; C:cell cortex; P:endocytosis; C:lamellipodium; P:Rac protein signal transduction; C:postsynaptic density |
|
|
contig03281 |
heparan sulfate 2-o-sulfotransferase 1 |
135 |
20 |
7.95E-20 |
95.70% |
5 |
C:Golgi membrane; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; P:heparin metabolic process; F:transferase activity; C:integral to membrane |
|
|
contig03282 |
---NA--- |
334 |
0 |
|
|
0 |
|
|
|
contig03283 |
dna helicase hel308 |
523 |
20 |
1.14E-63 |
81.70% |
5 |
P:DNA metabolic process; F:nucleic acid binding; C:single-stranded DNA-dependent ATP-dependent DNA helicase complex; F:single-stranded DNA-dependent ATP-dependent DNA helicase activity; F:ATP binding |
|
|
contig03284 |
---NA--- |
479 |
0 |
|
|
0 |
|
|
|
contig03285 |
cysteinyl-trna synthetase |
265 |
20 |
1.97E-42 |
89.30% |
7 |
C:cytoplasm; C:soluble fraction; P:cysteinyl-tRNA aminoacylation; F:ATP binding; F:zinc ion binding; F:tRNA binding; F:cysteine-tRNA ligase activity |
EC:6.1.1.16 |
|
contig03286 |
---NA--- |
466 |
0 |
|
|
0 |
|
|
|
contig03287 |
---NA--- |
225 |
0 |
|
|
0 |
|
|
|
contig03288 |
---NA--- |
680 |
0 |
|
|
0 |
|
|
|
contig03289 |
solute carrier family 12 (potassium chloride transporters) member 7 |
251 |
20 |
3.54E-28 |
81.90% |
7 |
C:integral to plasma membrane; F:potassium ion binding; F:potassium:chloride symporter activity; P:potassium ion transport; P:sodium ion transport; P:chloride transport; P:cell volume homeostasis |
|
|
contig03290 |
---NA--- |
786 |
0 |
|
|
0 |
|
|
|
contig03291 |
tuberous sclerosis 2 |
500 |
20 |
7.62E-21 |
68.00% |
28 |
P:regulation of focal adhesion assembly; P:transport; P:protein heterooligomerization; C:neuron projection; P:regulation of stress fiber assembly; P:negative regulation of TOR signaling pathway; P:phosphoinositide 3-kinase cascade; C:intracellular membrane-bounded organelle; C:growth cone; C:cytoskeletal part; P:regulation of small GTPase mediated signal transduction; C:microsome; P:protein kinase B signaling cascade; P:negative regulation of MAP kinase activity; C:cytosol; F:protein heterodimerization activity; P:transmembrane receptor protein tyrosine kinase signaling pathway; P:acute-phase response; P:negative regulation of Wnt receptor signaling pathway; P:regulation of cell cycle; C:protein complex; P:establishment of protein localization; P:negative regulation of epithelial cell proliferation; C:perinuclear region of cytoplasm; P:positive regulation of GTPase activity; P:protein homooligomerization; C:caveola; F:Rab GTPase activator activity |
|
|
contig03292 |
riken cdna 1200011m11 gene |
251 |
20 |
9.97E-23 |
85.25% |
0 |
|
|
|
contig03293 |
proteasome subunit beta type-5 precursor |
821 |
20 |
8.24E-133 |
88.00% |
8 |
P:response to oxidative stress; C:proteasome core complex; F:chymotrypsin activity; F:protein binding; F:threonine-type endopeptidase activity; P:proteasomal ubiquitin-dependent protein catabolic process; F:endopeptidase inhibitor activity; C:nucleus |
EC:3.4.21.1; EC:3.4.25.0 |
|
contig03294 |
seh1-like ( cerevisiae) |
539 |
20 |
6.92E-12 |
78.10% |
6 |
C:cytoplasm; C:nuclear pore; P:intracellular protein transmembrane transport; P:mRNA transport; F:calcium ion binding; P:cytoskeleton organization |
|
|
contig03295 |
---NA--- |
142 |
0 |
|
|
0 |
|
|
|
contig03296 |
17-beta hydroxysteroid dehydrogenase type 1 |
243 |
7 |
3.83E-14 |
88.29% |
6 |
C:cytoplasm; P:androgen metabolic process; P:estrogen biosynthetic process; F:binding; F:testosterone 17-beta-dehydrogenase activity; F:estradiol 17-beta-dehydrogenase activity |
EC:1.1.1.63; EC:1.1.1.62 |
|
contig03297 |
insulin-degrading enzyme |
454 |
20 |
9.37E-45 |
94.05% |
9 |
C:soluble fraction; C:extracellular space; F:signal transducer activity; C:peroxisome; P:sex differentiation; P:signal transduction; F:insulysin activity; P:proteolysis; F:zinc ion binding |
EC:3.4.24.56 |
|
contig03298 |
---NA--- |
355 |
0 |
|
|
0 |
|
|
|
contig03299 |
---NA--- |
523 |
0 |
|
|
0 |
|
|
|
contig03300 |
---NA--- |
310 |
0 |
|
|
0 |
|
|
|
100 Rows returned.